pyridostigmine bromide has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, XY; Kong, SS; Liu, JJ; Lu, Y; Qin, FF; Yu, XJ; Zang, WJ; Zhou, J | 1 |
| Huang, N; Liu, JJ; Lu, Y; Yang, Y; Yang, YH; Yu, XJ; Zang, WJ; Zhao, M | 1 |
2 other study(ies) available for pyridostigmine bromide and Fibrosis
| Article | Year |
|---|---|
Pyridostigmine ameliorates cardiac remodeling induced by myocardial infarction via inhibition of the transforming growth factor-β1/TGF-β1-activated kinase pathway.
Topics: Animals; Cholinesterase Inhibitors; Fibrosis; Hemodynamics; Hydroxyproline; Male; MAP Kinase Kinase Kinases; Matrix Metalloproteinase 2; Myocardial Infarction; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling | 2014 |
Improving vagal activity ameliorates cardiac fibrosis induced by angiotensin II: in vivo and in vitro.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Collagen; Constriction, Pathologic; Drug Evaluation, Preclinical; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Heart Diseases; Male; Pyridostigmine Bromide; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Vagus Nerve | 2015 |